J Lipid Atheroscler.  2013 Dec;2(2):91-95. 10.12997/jla.2013.2.2.91.

Successful Percutaneous Coronary Intervention in a Young Male Systemic Lupus Erythematosus Patient with Acute Myocardial Infarction

• Piao ZH
• Jeong MH
• Jeong HC
• Rhew SH
• Lee KH
• Park KH
• Sim DS
• Hong YJ
• Kim JH
• Ahn Y
• Cho JG
• Park JC

• KMID: 1845574
• DOI: http://doi.org/10.12997/jla.2013.2.2.91

Abstract

Acute myocardial infarction is a rare but potentially lethal complication of systemic lupus erythematosus. There are several proposed mechanisms for acute myocardial infarction in lupus patients: atherosclerosis and endothelial injury leading to plaque rupture, coronary vasculitis and inflammation of the vessel wall causing aneurismal dilatation or spasm, and acute thrombosis and embolism. We report a-37-year-old man with systemic lupus erythematosus who developed myocardial infarction twice. Potential mechanisms for acute myocardial infarction for this patient are discussed in this report.

Keyword

Percutaneous coronary intervention; Myocardial infarction; Systemic lupus erythematosus

MeSH Terms

Atherosclerosis
Dilatation
Embolism and Thrombosis
Humans
Inflammation
Lupus Erythematosus, Systemic*
Male*
Myocardial Infarction*
Percutaneous Coronary Intervention*
Rupture
Spasm
Vasculitis

Figure

• 

  Fig. 1 Twelve-lead electrocardiogram showed normal sinus rhythm and T-wave inversion in leads III, aVF and V5-V6.

• 

  Fig. 2 Coronary angiogram on second admission. (A) huge dilatations in the proximal three coronary arteries and soft plaque in the left anterior descending, (B) left circumflex artery, (C) right coronary artery, and total occlusion in the distal left circumflex artery.

• 

  Fig. 3 (A) A bare-metal stent (Coroflex stent) was implanted in the distal left circumflex artery, (B) The final angiogram showed good distal flow without residual stenosis.

Reference

1. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol. 1997; 145:408–415.

2. Svenungsson E, Jensen-Urstad K, Heimbürger M, Silveira A, Hamsten A, de Faire U, et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation. 2001; 104:1887–1893.

3. Haque S, Bruce IN. Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease. Nat Clin Pract Cardiovasc Med. 2005; 2:423–430.

4. Zeller CB, Appenzeller S. Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors. Curr Cardiol Rev. 2008; 4:116–122.

5. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001; 44:2331–2337.

6. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999; 340:115–126.

7. Korkmaz C, Cansu DU, Kaşifoğlu T. Myocardial infarction in young patients (< or =35 years of age) with systemic lupus erythematosus: a case report and clinical analysis of the literature. Lupus. 2007; 16:289–297.

8. Kim JY, Choi SH, Hong GR, Kang SM, Park YB, Rim SJ, et al. A case of Libman-Sacks endocarditis with moderate mitral regurgitation. Korean Circ J. 2003; 33:715–718.

9. Sumino H, Kanda T, Sasaki T, Kanazawa N, Takeuchi H. Myocardial infarction secondary to coronary aneurysm in systemic lupus erythematosus. An autopsy case. Angiology. 1995; 46:527–530.

10. Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003; 349:2407–2415.

11. Nikpour M, Urowitz MB, Gladman DD. Premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin North Am. 2005; 31:329–354.

12. Toloza SM, Uribe AG, McGwin G Jr, Alarcón GS, Fessler BJ, Bastian HM, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum. 2004; 50:3947–3957.

13. Sinicato NA, da Silva Cardoso PA, Appenzeller S. Risk factors in cardiovascular disease in systemic lupus erythematosus. Curr Cardiol Rev. 2013; 9:15–19.

14. Patel PJ, Matthai WH Jr, Untereker WJ. Effective management of acute coronary thrombosis in a young woman with lupus using aggressive medical therapy. Cardiology. 2011; 118:45–49.